AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2021
Feb 4, 2021
30237_dirs_2021-02-04_3705e7ab-92fe-4228-8f2a-3ded543edf4e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-02
Reporting Person: Wilkinson Peter J (SVP, Chief Accounting Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-02 | Restricted Stock Unit | $ | A | 350 | Acquired | Common Stock (350) | Direct | |
| 2021-02-02 | Non-qualified Stock Options | $233.39 | A | 1200 | Acquired | 2031-02-01 | Common Stock (1200) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on February 2, 2022.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5: The option vests in three equal annual installments beginning on the date reflected in this column.